Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Published Online: 2013-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alicia Frances Clare Okines•Andrew Wotherspoon•Claire Saffery•Clare Peckitt•David Cunningham•David Ferry•David Gonzalez•David Smith•Fareeda Coxon•Gary Middleton•Ian Chau•Jonathan Wadsley•Justin Waters•Sarah Slater•Stephen Falk•Timothy Iveson•Tom Crosby•Tom Waddell•Wasat Mansoor•Yolanda Barbachano
